Dr Ing hc F Porsche AG
XETRA:P911
Dr Ing hc F Porsche AG?
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
57.22
95.24
|
Price Target |
|
We'll email you a reminder when the closing price reaches EUR.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
What unique competitive advantages
does Dr Ing hc F Porsche AG hold over its rivals?
What risks and challenges
does Dr Ing hc F Porsche AG face in the near future?
Provide an overview of the primary business activities
of Dr Ing hc F Porsche AG.
Show me price targets
for Dr Ing hc F Porsche AG made by professional analysts.
Provide an overview of the primary business activities
of Dr Ing hc F Porsche AG.
What unique competitive advantages
does Dr Ing hc F Porsche AG hold over its rivals?
What risks and challenges
does Dr Ing hc F Porsche AG face in the near future?
Has there been any significant insider trading activity
in Dr Ing hc F Porsche AG recently?
Summarize the latest earnings call
of Dr Ing hc F Porsche AG.
Show all valuation multiples
for Dr Ing hc F Porsche AG.
Provide P/S
for Dr Ing hc F Porsche AG.
Provide P/E
for Dr Ing hc F Porsche AG.
Provide P/OCF
for Dr Ing hc F Porsche AG.
Provide P/FCFE
for Dr Ing hc F Porsche AG.
Provide P/B
for Dr Ing hc F Porsche AG.
Provide EV/S
for Dr Ing hc F Porsche AG.
Provide EV/GP
for Dr Ing hc F Porsche AG.
Provide EV/EBITDA
for Dr Ing hc F Porsche AG.
Provide EV/EBIT
for Dr Ing hc F Porsche AG.
Provide EV/OCF
for Dr Ing hc F Porsche AG.
Provide EV/FCFF
for Dr Ing hc F Porsche AG.
Provide EV/IC
for Dr Ing hc F Porsche AG.
Show me price targets
for Dr Ing hc F Porsche AG made by professional analysts.
What are the Revenue projections
for Dr Ing hc F Porsche AG?
How accurate were the past Revenue estimates
for Dr Ing hc F Porsche AG?
What are the Net Income projections
for Dr Ing hc F Porsche AG?
How accurate were the past Net Income estimates
for Dr Ing hc F Porsche AG?
What are the EPS projections
for Dr Ing hc F Porsche AG?
How accurate were the past EPS estimates
for Dr Ing hc F Porsche AG?
What are the EBIT projections
for Dr Ing hc F Porsche AG?
How accurate were the past EBIT estimates
for Dr Ing hc F Porsche AG?
Compare the revenue forecasts
for Dr Ing hc F Porsche AG with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Dr Ing hc F Porsche AG and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Dr Ing hc F Porsche AG against its competitors.
Analyze the profit margins
(gross, operating, and net) of Dr Ing hc F Porsche AG compared to its peers.
Compare the P/E ratios
of Dr Ing hc F Porsche AG against its peers.
Discuss the investment returns and shareholder value creation
comparing Dr Ing hc F Porsche AG with its peers.
Analyze the financial leverage
of Dr Ing hc F Porsche AG compared to its main competitors.
Show all profitability ratios
for Dr Ing hc F Porsche AG.
Provide ROE
for Dr Ing hc F Porsche AG.
Provide ROA
for Dr Ing hc F Porsche AG.
Provide ROIC
for Dr Ing hc F Porsche AG.
Provide ROCE
for Dr Ing hc F Porsche AG.
Provide Gross Margin
for Dr Ing hc F Porsche AG.
Provide Operating Margin
for Dr Ing hc F Porsche AG.
Provide Net Margin
for Dr Ing hc F Porsche AG.
Provide FCF Margin
for Dr Ing hc F Porsche AG.
Show all solvency ratios
for Dr Ing hc F Porsche AG.
Provide D/E Ratio
for Dr Ing hc F Porsche AG.
Provide D/A Ratio
for Dr Ing hc F Porsche AG.
Provide Interest Coverage Ratio
for Dr Ing hc F Porsche AG.
Provide Altman Z-Score Ratio
for Dr Ing hc F Porsche AG.
Provide Quick Ratio
for Dr Ing hc F Porsche AG.
Provide Current Ratio
for Dr Ing hc F Porsche AG.
Provide Cash Ratio
for Dr Ing hc F Porsche AG.
What is the historical Revenue growth
over the last 5 years for Dr Ing hc F Porsche AG?
What is the historical Net Income growth
over the last 5 years for Dr Ing hc F Porsche AG?
What is the current Free Cash Flow
of Dr Ing hc F Porsche AG?
Discuss the annual earnings per share (EPS)
trend over the past five years for Dr Ing hc F Porsche AG.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
DE |
Dr Ing hc F Porsche AG
XETRA:P911
|
54.4B EUR | 3.6 | ||
US |
Tesla Inc
NASDAQ:TSLA
|
1.3T USD | 92.8 |
|
|
JP |
Toyota Motor Corp
TSE:7203
|
39.5T JPY | 6.3 |
|
|
CN |
BYD Co Ltd
SZSE:002594
|
783.7B CNY | 17.8 |
|
|
IT |
Ferrari NV
MIL:RACE
|
81.4B EUR | 33.7 |
|
|
DE |
Mercedes Benz Group AG
MIL:MBG
|
75.3B EUR | 4.5 |
|
|
DE |
Daimler AG
XETRA:DAI
|
67.5B EUR | 4 |
|
|
DE |
Mercedes-Benz Group AG
XETRA:MBG
|
55.2B EUR | 5.2 |
|
|
US |
General Motors Co
NYSE:GM
|
56.1B USD | 4.5 |
|
|
DE |
Bayerische Motoren Werke AG
XETRA:BMW
|
47.1B EUR | 3.8 |
|
|
JP |
Honda Motor Co Ltd
TSE:7267
|
7.3T JPY | 3.9 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
DE |
Dr Ing hc F Porsche AG
XETRA:P911
|
Average EV/EBITDA:
16.4
3.6
|
4%
|
0.9 | ||
US |
Tesla Inc
NASDAQ:TSLA
|
92.8
|
22%
|
4.2 |
|
|
JP |
Toyota Motor Corp
TSE:7203
|
6.3
|
-2%
|
N/A |
|
|
CN |
BYD Co Ltd
SZSE:002594
|
17.8
|
61%
|
0.3 |
|
|
IT |
Ferrari NV
MIL:RACE
|
33.7
|
12%
|
2.8 |
|
|
DE |
Mercedes Benz Group AG
MIL:MBG
|
4.5
|
4%
|
1.1 |
|
|
DE |
Daimler AG
XETRA:DAI
|
4
|
N/A | N/A |
|
|
DE |
Mercedes-Benz Group AG
XETRA:MBG
|
5.2
|
-4%
|
N/A |
|
|
US |
General Motors Co
NYSE:GM
|
4.5
|
-5%
|
N/A |
|
|
DE |
Bayerische Motoren Werke AG
XETRA:BMW
|
3.8
|
-3%
|
N/A |
|
|
JP |
Honda Motor Co Ltd
TSE:7267
|
3.9
|
1%
|
3.9 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.